JAPAN DOMESTIC PHARMA- Competitive Landscape of Leading Therapy Classes - UPDATE

March 2012 | 27 pages | ID: J74A95CF5F0EN
MP Advisors

Abstracts

In this updated issue of ‘Japan-Domestic Pharma Market Summary’ for 2012, we present major 10 Thx Class in Japan which covers ~40% of total Japan domestic pharma market (~¥8.0 trillion). This will give you comprehensive scenarios of – 1) Key drugs and player 2) Their annual sales along with derived market share and the trends. 3) The leading pipeline candidates in each therapeutic class to keep an eye over expected breakthroughs in each class – which includes products from all pharma companies operating in Japan including MNCs.

Contents

1. HYPERTENSION

I ARB, ACE Inhibitors
  Leading Products Market share Trend and Sales in the class
II ARB, ACE Inhibitors
  Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

2. ANTI-CANCER

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

3. CHOLESTEROL LOWERING

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

4. ALLERGY

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

5. ANTIBIOTICS

I Antibiotics (Oral)
  Leading Products Market share Trend and Sales in the class
II Antibiotics (Injection)
  Leading Products Market share Trend and Sales in the class
III Antibiotics (Quinolones)
  Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

6. PEPTIC ULCER

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

7. DIABETES

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

8. ANTI-VIRUS

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

9. ANTI-INFLAMMATORY

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

10. OSTEOPOROSIS

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

11. RHEUMATOID ARTHIRITIS

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

12. CEREBRAL-PROTECTIVE AGENTS

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

13. SCHIZOPHRENIA

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

14. ANTI-DEPRESSANTS

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

15. HYPNOTICS, SEDATIVES

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

16. ANTI-PARKINSONISM

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class

17. ANTI-EPILEPTICS

Leading Products Market share Trend and Sales in the class
Major Pipeline Candidates in the Class